- Home
- ADVM vs ALTO Comparison
ADVM vs ALTO Comparison
Compare ADVM & ALTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- ALTO
- Stock Information
- Founded
- ADVM 2006
- ALTO 2003
- Country
- ADVM United States
- ALTO United States
- Employees
- ADVM N/A
- ALTO N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- ALTO Major Chemicals
- Sector
- ADVM Health Care
- ALTO Industrials
- Exchange
- ADVM Nasdaq
- ALTO Nasdaq
- Market Cap
- ADVM 94.6M
- ALTO 90.6M
- IPO Year
- ADVM 2014
- ALTO N/A
- Fundamental
- Price
- ADVM $4.48
- ALTO $1.21
- Analyst Decision
- ADVM Strong Buy
- ALTO Strong Buy
- Analyst Count
- ADVM 4
- ALTO 1
- Target Price
- ADVM $19.75
- ALTO $5.50
- AVG Volume (30 Days)
- ADVM 800.9K
- ALTO 448.3K
- Earning Date
- ADVM 11-03-2025
- ALTO 11-05-2025
- Dividend Yield
- ADVM N/A
- ALTO N/A
- EPS Growth
- ADVM N/A
- ALTO N/A
- EPS
- ADVM N/A
- ALTO N/A
- Revenue
- ADVM $1,000,000.00
- ALTO $933,137,000.00
- Revenue This Year
- ADVM $1,449.40
- ALTO N/A
- Revenue Next Year
- ADVM N/A
- ALTO $7.53
- P/E Ratio
- ADVM N/A
- ALTO N/A
- Revenue Growth
- ADVM N/A
- ALTO N/A
- 52 Week Low
- ADVM $1.78
- ALTO $0.76
- 52 Week High
- ADVM $8.56
- ALTO $2.05
- Technical
- Relative Strength Index (RSI)
- ADVM 53.05
- ALTO 59.37
- Support Level
- ADVM $4.11
- ALTO $1.07
- Resistance Level
- ADVM $5.59
- ALTO $1.17
- Average True Range (ATR)
- ADVM 0.52
- ALTO 0.06
- MACD
- ADVM -0.09
- ALTO 0.01
- Stochastic Oscillator
- ADVM 27.75
- ALTO 94.74
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
About ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, Western production, and Others.